Eradication of hepatitis C virus infection among patients coinfected with HIV was associated with reductions in diabetes and chronic renal failure in addition to reduced mortality, HIV progression and liver-related events, according to the results of a Spanish cohort study. These findings led investigators to conclude that HIV coinfected patients should receive HCV therapy regardless of their fibrosis stage.
31 January 2017 | Healio
A new study suggests the diabetes prevalence is much higher among HIV-positive individuals than the general population, even when obesity is not present.
31 January 2017 | HIV / AIDS News From Medical News Today
A diabetes drug may have benefits beyond lower blood sugar in patients with HIV. New research from Washington University School of Medicine in St. Louis suggests the drug may prevent cardiovascular problems because it works to reduce inflammation that is linked to heart disease and stroke in these patients. The drug both improved metabolism and reduced inflammation in HIV-positive adults on antiretroviral therapy.
15 May 2015 | Eurekalert Medicine & Health
It is time to act and no time to waste. That is the urgent message of the report "The Looming Co-epidemic of TB-Diabetes: A Call to Action" launched jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and the World Diabetes Foundation (WDF) at the opening day of the 45th Union World Conference on Lung Health in Barcelona. The report warns against the brewing storm of diabetes and tuberculosis (TB) that is no longer confined to the teacup.
29 October 2014 | Citizen News Service
The report, The Looming Co-epidemic of TB Diabetes: A Call to Action (1), launched on the opening day of the 45th Union World Conference on Lung Health currently taking place in Barcelona, Spain October 28 - November 1, synthesizes evidence from the medical and scientific literature, promotes an international policy framework for action, and lays out a new research agenda to fill knowledge gaps. The report challenges the conventional approach to health policymaking, which has historically addressed infectious diseases and noncommunicable (or “chronic”) diseases independently.
29 October 2014 | International Union Against Tuberculosis and Lung Disease
As effective treatments for HIV become more widely available in low-income and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV. An update on non-communicable diseases among HIV-positive populations in low-income and middle-income countries appears as a supplement to in JAIDS: Journal of Acquired Immune Deficiency Syndromes. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
14 August 2014 | Eurekalert Medicine & Health
One of the most feared diseases in the world is now, for British doctors, a manageable chronic condition. It’s a triumph we’re oddly scared to talk about
17 April 2014 | The Spectator
This issue of Research Initiative, Treatment Action (RITA!) carefully examines evidence from well over 100 studies on cardiovascular risk factors and the impact of individual and combined antiretrovirals on the heart.This RITA! also features an interview with the University of Wisconsin’s James Stein, perhaps the leading authority on cardiovascular disease in people with HIV. Stein offers frank and insightful answers to questions on cardiovascular risk, screening adults and children, the Framingham score, lipid targets, aspirin prophylaxis, and smoking.
20 June 2013 | RITA! / Center for AIDS Information and Advocacy
Government's annual death report has confirmed the trend that less South Africans have been dying of HIV/AIDS-related diseases. However, more people are dying of non-communicable diseases such as diabetes. ...
11 April 2013 | AllAfrica.com
Researchers at the University of Virginia School of Medicine have determined the molecular structure of a protein whose mutations have been linked to several early aging diseases, and to side effects of common HIV and AIDS medications.
11 April 2013 | University of Virginia press release